IVA
Inventiva S.A.
Phase 3
AI-extracted
lanifibranor
metabolic dysfunction-associated steatohepatitis (MASH)
T-minus 177 days
~ Dec 31, 2026
SEC 6-K
verified 12h ago
Countdown card →